4SC AG
Announcement: 4SC to present at the upcoming Kempen & Co Life Sciences Conference
4SC AG / Key word(s): Conference Announcement 4SC to present at the upcoming Kempen & Co Life Sciences Conference Planegg-Martinsried, Germany, 10 April 2015 – 4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer and autoimmune diseases, will present the Company at the upcoming Kempen & Co Life Sciences Conference in New York (USA) to investors and financial analysts. 8th Kempen & Co Life Sciences Conference: End of release About 4SC Cautionary statement regarding forward-looking statements For more information please visit www.4sc.com or contact: 4SC AG MC Services The Trout Group 2015-04-10 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
Language: | English | |
Company: | 4SC AG | |
Am Klopferspitz 19a | ||
82152 Martinsried | ||
Germany | ||
Phone: | +49 (0)89 7007 63-0 | |
Fax: | +49 (0)89 7007 63-29 | |
E-mail: | public@4sc.com | |
Internet: | www.4sc.de | |
ISIN: | DE0005753818 | |
WKN: | 575381 | |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart | |
End of News | DGAP News-Service |
342783 2015-04-10 |